home / stock / vcnx / vcnx short
Short Information | Vaccinex Inc. (NASDAQ:VCNX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 50,132 |
Total Actual Volume | 194,717 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 1 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 2,507 |
Average Short Percentage | 20.81% |
Is there a VCNX Short Squeeze or Breakout about to happen?
See the VCNX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-27-2024 | $7.6 | $7.45 | $7.6 | $7.45 | 3,442 | 427 | 12.41% |
03-26-2024 | $7.83 | $7.55 | $7.91 | $7.55 | 2,671 | 347 | 12.99% |
03-25-2024 | $7.795 | $7.755 | $7.795 | $7.75 | 2,262 | 310 | 13.7% |
03-22-2024 | $8.23 | $7.87 | $8.23 | $7.46 | 5,933 | 381 | 6.42% |
03-21-2024 | $8.12 | $8.21 | $8.4 | $8.12 | 4,323 | 594 | 13.74% |
03-20-2024 | $8.06 | $8.299 | $8.35 | $8.02 | 8,157 | 1,483 | 18.18% |
03-19-2024 | $8.27 | $8.28 | $8.63 | $8.04 | 7,669 | 176 | 2.29% |
03-18-2024 | $8.06 | $8.2 | $8.73 | $8.06 | 2,962 | 404 | 13.64% |
03-15-2024 | $8.4 | $8.05 | $8.5154 | $8.05 | 13,568 | 1,051 | 7.75% |
03-14-2024 | $8.3 | $8.39 | $8.53 | $8.11 | 5,614 | 985 | 17.55% |
03-13-2024 | $8.26 | $8.56 | $8.63 | $8.26 | 2,489 | 395 | 15.87% |
03-12-2024 | $8.55 | $8.14 | $9.34 | $8.12 | 25,105 | 8,761 | 34.9% |
03-11-2024 | $8.62 | $8.549 | $8.62 | $8.3403 | 4,340 | 1,181 | 27.21% |
03-08-2024 | $8.5 | $8.65 | $8.8999 | $8.11 | 18,688 | 2,433 | 13.02% |
03-07-2024 | $7.94 | $8.29 | $8.4999 | $7.9008 | 24,473 | 10,950 | 44.74% |
03-06-2024 | $7.92 | $7.96 | $7.9899 | $7.67 | 9,987 | 3,114 | 31.18% |
03-05-2024 | $7.66 | $8.2 | $8.3 | $7.66 | 11,975 | 4,143 | 34.6% |
03-04-2024 | $8.26 | $7.6 | $8.6 | $7.6 | 27,747 | 8,660 | 31.21% |
03-01-2024 | $9.05 | $8.75 | $9.23 | $8.7 | 6,588 | 811 | 12.31% |
02-29-2024 | $9.1226 | $8.801 | $9.2 | $8.801 | 6,724 | 3,526 | 52.44% |
News, Short Squeeze, Breakout and More Instantly...
ROCHESTER, N.Y., March 27, 2024 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease and cancer through the inhibition of SEMA...
2024-03-08 11:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platform enable...